These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 15385441)

  • 1. Evolution of the tumor suppressor BRCA1 locus in primates: implications for cancer predisposition.
    Pavlicek A; Noskov VN; Kouprina N; Barrett JC; Jurka J; Larionov V
    Hum Mol Genet; 2004 Nov; 13(22):2737-51. PubMed ID: 15385441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolutionary conservation analysis increases the colocalization of predicted exonic splicing enhancers in the BRCA1 gene with missense sequence changes and in-frame deletions, but not polymorphisms.
    Pettigrew C; Wayte N; Lovelock PK; Tavtigian SV; Chenevix-Trench G; Spurdle AB; Brown MA
    Breast Cancer Res; 2005; 7(6):R929-39. PubMed ID: 16280041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast/ovarian cancer families.
    Montagna M; Santacatterina M; Torri A; Menin C; Zullato D; Chieco-Bianchi L; D'Andrea E
    Oncogene; 1999 Jul; 18(28):4160-5. PubMed ID: 10435598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17.
    Puget N; Torchard D; Serova-Sinilnikova OM; Lynch HT; Feunteun J; Lenoir GM; Mazoyer S
    Cancer Res; 1997 Mar; 57(5):828-31. PubMed ID: 9041180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based assessment of missense mutations in human BRCA1: implications for breast and ovarian cancer predisposition.
    Mirkovic N; Marti-Renom MA; Weber BL; Sali A; Monteiro AN
    Cancer Res; 2004 Jun; 64(11):3790-7. PubMed ID: 15172985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin.
    Preisler-Adams S; Schönbuchner I; Fiebig B; Welling B; Dworniczak B; Weber BH
    Cancer Genet Cytogenet; 2006 Jul; 168(1):44-9. PubMed ID: 16772120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Missense mutations in the BRCT domain of BRCA-1 from high-risk women frequently perturb strongly hydrophobic amino acids conserved among mammals.
    Figge MA; Blankenship L
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1037-41. PubMed ID: 15184261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Missense mutations of BRCA1 gene affect the binding with p53 both in vitro and in vivo.
    Quaresima B; Faniello MC; Baudi F; Crugliano T; Di Sanzo M; Cuda G; Costanzo F; Venuta S
    Oncol Rep; 2006 Oct; 16(4):811-5. PubMed ID: 16969499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid detection of novel BRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments.
    Casilli F; Di Rocco ZC; Gad S; Tournier I; Stoppa-Lyonnet D; Frebourg T; Tosi M
    Hum Mutat; 2002 Sep; 20(3):218-26. PubMed ID: 12203994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family.
    Palanca Suela S; Esteban Cardeñosa E; Barragán González E; Oltra Soler S; de Juan Jiménez I; Chirivella González I; Segura Huerta A; Guillén Ponce C; Martínez de Dueñas E; Bolufer Gilabert P;
    Breast Cancer Res Treat; 2008 Nov; 112(1):63-7. PubMed ID: 18060491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families.
    Hansen Tv; Jønson L; Albrechtsen A; Andersen MK; Ejlertsen B; Nielsen FC
    Breast Cancer Res Treat; 2009 May; 115(2):315-23. PubMed ID: 18546071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MLPA screening in the BRCA1 gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases.
    Engert S; Wappenschmidt B; Betz B; Kast K; Kutsche M; Hellebrand H; Goecke TO; Kiechle M; Niederacher D; Schmutzler RK; Meindl A
    Hum Mutat; 2008 Jul; 29(7):948-58. PubMed ID: 18431737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo Alu element insertions targeted to a sequence common to the BRCA1 and BRCA2 genes.
    Teugels E; De Brakeleer S; Goelen G; Lissens W; Sermijn E; De Grève J
    Hum Mutat; 2005 Sep; 26(3):284. PubMed ID: 16088935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions.
    Puget N; Stoppa-Lyonnet D; Sinilnikova OM; Pagès S; Lynch HT; Lenoir GM; Mazoyer S
    Cancer Res; 1999 Jan; 59(2):455-61. PubMed ID: 9927062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel genomic rearrangements in the BRCA1 gene detected in Greek breast/ovarian cancer patients.
    Armaou S; Konstantopoulou I; Anagnostopoulos T; Razis E; Boukovinas I; Xenidis N; Fountzilas G; Yannoukakos D
    Eur J Cancer; 2007 Jan; 43(2):443-53. PubMed ID: 17174087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of a novel Alu-mediated BRCA1 exon 13 duplication in Chinese breast cancer patients and implications for genetic testing.
    Yap KP; Ang P; Lim IH; Ho GH; Lee AS
    Clin Genet; 2006 Jul; 70(1):80-2. PubMed ID: 16813611
    [No Abstract]   [Full Text] [Related]  

  • 17. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic rearrangements in the BRCA1 and BRCA2 genes.
    Mazoyer S
    Hum Mutat; 2005 May; 25(5):415-22. PubMed ID: 15832305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marsupial BRCA1: conserved regions in mammals and the potential effect of missense changes.
    Ramirez CJ; Fleming MA; Potter JD; Ostrander GK; Ostrander EA
    Oncogene; 2004 Mar; 23(9):1780-8. PubMed ID: 15001988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
    Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.